Funding for the this work, and as cited 2,10, was provided, in part, by a research grant awards to MF Salvatore from the American Federation for Aging Research, The Edward P. Stiles Trust Fund and Biomedical Research Foundation of Northwest Louisiana, and to BS Pruett from the Ike Muslow Predoctoral Fellowship, LSU Health Sciences Center-Shreveport.

<ol>
	<li>Trevitt, J. T., Carlson, B. B., Nowend, K., Salamone, J. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Substantia+nigra+pars+reticulate+is+a+highly+potent+site+of+action+for+the+behavioral+effects+of+the+D1+antagonist+SCH23390+in+rat.">Substantia nigra pars reticulate is a highly potent site of action for the behavioral effects of the D1 antagonist SCH23390 in rat.</a> Psychopharmacology. 156, 32-41 (2001).</li><li>Salvatore, M. F., Pruett, B. S., Spann, S. L., Dempsey, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Aging+reveals+a+role+for+nigral+tyrosine+hydroxylase+ser31+phosphorylation+in+locomotor+activity+generation.">Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generation.</a> PLoS ONE. 4, e8466 (2009).</li><li>Rossato, J. L., Bevilaqua, L. R. M., Izquierdo, I., Medina, J. H., Cammarota, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Dopamine+controls+persistence+of+long-term+memory+storage.">Dopamine controls persistence of long-term memory storage.</a> Science. 325, 1017-1020 (2009).</li><li>Keller, C. M., Salvatore, M. F., Pruett, B. S., Guerdin, G. F., Goeders, N. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biphasic+dopamine+regulation+in+mesoaccumbens+pathway+in+response+to+non-contigent+binge+and+escalating+methamphetamine+regimens+in+the+Wistar+rat.">Biphasic dopamine regulation in mesoaccumbens pathway in response to non-contigent binge and escalating methamphetamine regimens in the Wistar rat.</a> Psychopharmacology. 215, 513-526 (2011).</li><li>Lu, L., Dempsey, J., Liu, S. Y., Bossert, J. M., Shaham, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+single+infusion+of+brain-derived+neurotrophic+factor+into+the+ventral+tegmental+area+induces+long-lasting+potentiation+of+cocaine+seeking+after+withdrawal.">A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal.</a> J. Neurosci. 24, 1604-1611 (2004).</li><li>Hoffer, B. J., Hoffman, A., Bowenkamp, K., Huettl, P., Hudson, J., Martin, D., Lin, L. F., Gerhardt, G. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Glial+cell+line-derived+neurotrophic+factor+reverses+toxin-induced+injury+to+midbrain+dopaminergic+neurons+in+vivo.">Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo.</a> Neurosci. Lett. 182, 107-111 (1994).</li><li>Salvatore, M. F., Zhang, J. L., Large, D. M., Wilson, P. E., Gash, C. R., Thomas, T. C., Haycock, J. W., Bing, G., Stanford, J. A., Gash, D. M., Gerhardt, G. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Striatal+GDNF+administration+increases+tyrosine+hydroxylase+phosphorylation+in+the+rat+striatum+and+substantia+nigra.">Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.</a> J. Neurochem. 90, 245-254 (2004).</li><li>Lu, L., Wang, X., Wu, P., Xu, C., Zhao, M., Morales, M., Harvey, B. K., Hoffer, B. J., Shaham, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Role+of+ventral+tegmental+area+glial+cell-line+derived+neurotrophic+factor+in+incubation+of+cocaine+craving.">Role of ventral tegmental area glial cell-line derived neurotrophic factor in incubation of cocaine craving.</a> Biol. Psychiatry. 66, 137-145 (2009).</li><li>Lavicky, J., Dunn, A. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Corticotropin-releasing+factor+stimulates+catecholamine+release+in+hypothalamus+and+prefrontal+cortex+in+freely+moving+rats+as+assessed+by+microdialysis.">Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis.</a> J. Neurochem. 60, 602-612 (1993).</li><li>Salvatore, M. F., Pruett, B. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Dichotomy+of+tyrosine+hydroxylase+and+dopamine+regulation+between+somatodendritic+and+terminal+field+areas+of+nigrostriatal+and+mesoaccumbens+pathways.">Dichotomy of tyrosine hydroxylase and dopamine regulation between somatodendritic and terminal field areas of nigrostriatal and mesoaccumbens pathways.</a> PLoS ONE. 7, e29867 (2012).</li><li>Salvatore, M. F., Garcia-Espana, A., Goldstein, M., Deutch, A. Y., Haycock, J. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Stoichiometry+of+tyrosine+hydroxylase+phosphorylation+in+the+nigrostriatal+and+mesolimbic+systems+in+vivo:+Effects+of+acute+haloperidol+and+related+compounds.">Stoichiometry of tyrosine hydroxylase phosphorylation in the nigrostriatal and mesolimbic systems in vivo: Effects of acute haloperidol and related compounds.</a> J. Neurochem. 75, 225-232 (2000).</li><li>Salvatore, M. F., Waymire, J. C., Haycock, J. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Depolarization-stimulated+catecholamine+biosynthesis:+involvement+of+protein+kinases+and+tyrosine+hydroxylase+phosphorylation+sites+in+situ.">Depolarization-stimulated catecholamine biosynthesis: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ.</a> J. Neurochem. 79, 349-360 (2001).</li><li>Haycock, J. W., Lew, J. Y., Garcia-Espana, A., Lee, K. Y., Harada, K., Meller, E., Goldstein, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Role+of+serine-19+phosphorylation+in+regulating+tyrosine+hydroxylase+studied+with+site-+and+phosphospecific+antibodies+and+site-directed+mutagenesis.">Role of serine-19 phosphorylation in regulating tyrosine hydroxylase studied with site- and phosphospecific antibodies and site-directed mutagenesis.</a> J. Neurochem. 71, 1670-1675 (1998).</li><li>Lindgren, N., Xu, Z. Q., Linskog, M., Herrera-Marschitz, M., Goiny, M., Haycock, J. W., Goldstein, M., Hokfelt, T., Fisone, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Regulation+of+tyrosine+hydroxylase+activity+and+phosphorylation+at+ser19+and+ser40+via+activation+of+glutamate+NMDA+receptors+in+rat+striatum.">Regulation of tyrosine hydroxylase activity and phosphorylation at ser19 and ser40 via activation of glutamate NMDA receptors in rat striatum.</a> J. Neurochem. 74, 2470-2477 (2000).</li></ol>

No conflicts of interest declared.

As outlined in Figure 1, the methods detailed above should yield multiple readouts of dopamine and its regulating proteins TH, DAT, and VMAT2 from one sample of SN or VTA obtained from either the rat or mouse. Again, the benefits of carrying out this protocol are that the investigator can obtain operationally-matched readouts of how dopamine is regulated in vivo under virtually any experimental paradigm and, in doing so, save significant experimental resources by reducing the number of animals required in any ex...

HPLC system:
The basic system consists of a Shimadzu LC10-ADvp HPLC pump, a Waters WISP 717 automatic sample injector, a 250 X 4.4 mm 5 micron Spherosorb ODS-1 C18 reverse-phase column (Waters), a Bioanalytical Systems (BAS) TL12 dual glassy carbon electrode, two BAS LC4B electrochemical detectors, and a Waters Empower 2 data collection and integration system.
The column is maintained at 30-45&deg;C (BAS LC22A column heater). The mobile phase is 0.1 M sodium phosphate (pH 3.0), 0.1 mM EDTA, 0.2-0.4 mM 1-Octane Sulfonic Acid (Eastman-Kodak), and 0.35% acetonitrile (v/v), filtered through a 0.45 micron filter. Flow rate is of 1.2 ml/min. Four liter batches of mobile phase are optimized for separations by adjusting the pH, Octane Sulfonic Acid and column temperature. The mobile phase is recycled, and is continuously purged with helium gas to remove dissolved oxygen. Recycling of the mobile phase is almost essential to maintain good resolution for a reasonable period of time. The mobile phase shelf-life is maintained by using a flow switch (controlled by the integrator) to divert to waste the first 2-7 min of each run.
The electrodes are maintained at potentials of approximately 0.78 and 0.95V with respect to a Ag/AgC1 reference electrode. The electrode at the higher potential is used exclusively for the determination of tryptophan (and the NMDA internal standard). The 0.78 V potential provides a superior signal to noise ratio for detection of the monoamines and compounds, other than tryptophan. The chromatograms are stored on the hard drive of the Empower workstation, and subsequently processed and the data transferred directly into an Excel spreadsheet for computation of metabolite amounts and compilation of group data. 
Pump: Shimadzu LC-10AD Cell: BAS Cross Flow. Glassy carbon working electrode at 0.780 and 0.950 V potential. Detector: BAS LC-4B operated in dual channel mode. Data Acq. System: Waters Empower Pro 2. Injector: Waters WISP 717 Column: Waters Spherosorb ODS-1, 5 &mu;M particle, 4.4 mm X 250 mm.
<table border="1">
 <tbody>
 <tr>
 <td>Name of the reagent</td>
 <td>Company</td>
 <td>Catalogue number</td>
 </tr>
 <tr>
 <td>Sodium Dodecyl Sulfate (SDS)</td>
 <td>- J.T. Baker</td>
 <td>4095-02</td>
 </tr>
 <tr>
 <td>Trizma Base</td>
 <td>Sigma</td>
 <td>T1503-1KG </td>
 </tr>
 <tr>
 <td>Trizma HCl </td>
 <td>Sigma </td>
 <td>T3253-1KG </td>
 </tr>
 <tr>
 <td>Glycerol</td>
 <td>Sigma</td>
 <td>G8773-500 mL</td>
 </tr>
 <tr>
 <td>PVP-40</td>
 <td>Sigma</td>
 <td>PVP40-1KG</td>
 </tr>
 <tr>
 <td>dPBS </td>
 <td>Gibco </td>
 <td>21600-069</td>
 </tr>
 <tr>
 <td>Tween20 </td>
 <td>Sigma </td>
 <td>P1379-500 mL </td>
 </tr>
 <tr>
 <td>Glycine </td>
 <td>Sigma </td>
 <td>G8898-1KG </td>
 </tr>
 <tr>
 <td>Ponceau S </td>
 <td>Fluka </td>
 <td>81460</td>
 </tr>
 <tr>
 <td>Bromophenol Blue </td>
 <td>Sigma </td>
 <td>B8026-5G</td>
 </tr>
 <tr>
 <td>Dithiothreitol </td>
 <td>Sigma </td>
 <td>D-9163 </td>
 </tr>
 <tr>
 <td>Protein Standard 2 mg BSA</td>
 <td>Sigma</td>
 <td>P5619-25VL</td>
 </tr>
 <tr>
 <td>Pierce BCA Protein Assay Reagent A</td>
 <td>Thermo- Fisher Scientific</td>
 <td>23223</td>
 </tr>
 <tr>
 <td>Precision Plus Protein Standard</td>
 <td>Bio Rad</td>
 <td>161-0373</td>
 </tr>
 <tr>
 <td>[125I]-protein A, specific activity</td>
 <td>Perkin-Elmer</td>
 <td>&nbsp;</td>
 </tr>
 </tbody>
</table>
Table 2. Specific reagents.
<table border="1">
 <tbody>
 <tr>
 <td>Reagents</td>
 <td>Formulas</td>
 </tr>
 <tr>
 <td>10% SDS</td>
 <td>10 g SDS, 100 mL DI H20 </td>
 </tr>
 <tr>
 <td>1% SDS (pH to 8.2)</td>
 <td><ol>
 <li>10 mL 10%SDS </li>
 <li>60.5 mg Trizma Base </li>
 <li>37.22 mg EDTA </li>
 <li>90 mL DI H20 </li>
 </ol></td>
 </tr>
 <tr>
 <td>Copper II Sulfate Solution </td>
 <td><ol>
 <li>1 g Copper II sulfate </li>
 <li>25 mL DI H20 </li>
 </ol></td>
 </tr>
 <tr>
 <td>3X Sample Buffer </td>
 <td><ol>
 <li>Trizma Base 2.27 g </li>
 <li>SDS 6 g</li>
 <li>Dithiothreitol 0.463 g</li>
 <li>Glycerol 30 g</li>
 <li>Bromophenol Blue 10 mg</li>
 <li>D I H20 (initially add above reagents to 40 mL of H20 in a graduated cylinder; then add H20 until volume reaches 100 mL)</li>
 <li>HCl (add as needed to reach pH of 6.85)</li>
 <li>Freeze solution in 50 2.0 mL tubes. </li>
 </ol>
 (makes 100 mL): Volume of 3X Sample Buffer needed = &frac12; volume of SDS used in sample.</td>
 </tr>
 <tr>
 <td>1X Sample Buffer</td>
 <td>Dilute 3X Sample Buffer down to 1X sample buffer using DI H20 </td>
 </tr>
 <tr>
 <td>10X Running Buffer (Makes 4 L)</td>
 <td><ol>
 <li>Trizma Base 121.1 g</li>
 <li>Glycine 577 g</li>
 <li>SDS 40 g</li>
 </ol></td>
 </tr>
 <tr>
 <td>10X Transfer Buffer: (Makes 4 L)</td>
 <td><ol>
 <li>Glycine 360 g</li>
 <li>Trizma Base 96 g</li>
 </ol></td>
 </tr>
 <tr>
 <td>Ponceau</td>
 <td><ol>
 <li>Ponceau S. 0.5 g</li>
 <li>Acetic Acid 5 mL</li>
 <li>DI H20 95 mL</li>
 </ol></td>
 </tr>
 <tr>
 <td>.2% HCl Solution</td>
 <td>5.2 mL HCl in 500mL of DI H20 </td>
 </tr>
 <tr>
 <td>PVP-T20 Blocking Soln. (Makes 4 L)</td>
 <td><ol>
 <li>PVP-40 40 g</li>
 <li>dPBS 38.2 g</li>
 <li>Tween20 2 g</li>
 <li>Thimerisol 0.4 g</li>
 <li>1M Tris pH 7.6 (60.6 g Tris HCl + 13.9 g Tris Base in 500 mL DI H20)- 50 mL </li>
 </ol></td>
 </tr>
 <tr>
 <td>10X Blot Buffer (Makes 4 L)</td>
 <td><ol>
 <li>Tween 20 20 g</li>
 <li>Tris Base 14 g</li>
 <li>Tris HCl 61 g</li>
 </ol></td>
 </tr>
 </tbody>
</table>
Table 3. Protein Assay and Western Blotting Formulas.
Tyrosine hydroxylase standards: The calibrated TH protein and phosphorylation standards used by this laboratory are derived from PC12 cell extracts, which were analyzed for TH protein content and phosphorylation stoichiometries against a previously calibrated TH standards that ultimately originated from the laboratory of Dr. John Haycock 11.

comprehensive profiling of dopamine regulation in substantia nigra and ventral tegmental area

Dopamine is a vigorously studied neurotransmitter in the CNS. Indeed, its involvement in locomotor activity and reward-related behaviour has fostered five decades of inquiry into the molecular deficiencies associated with dopamine regulation. The majority of these inquiries of dopamine regulation in the brain focus upon the molecular basis for its regulation in the terminal field regions of the nigrostriatal and mesoaccumbens pathways; striatum and nucleus accumbens. Furthermore, such studies have concentrated on analysis of dopamine tissue content with normalization to only wet tissue weight. Investigation of the proteins that regulate dopamine, such as tyrosine hydroxylase (TH) protein, TH phosphorylation, dopamine transporter (DAT), and vesicular monoamine transporter 2 (VMAT2) protein often do not include analysis of dopamine tissue content in the same sample. The ability to analyze both dopamine tissue content and its regulating proteins (including post-translational modifications) not only gives inherent power to interpreting the relationship of dopamine with the protein level and function of TH, DAT, or VMAT2, but also extends sample economy. This translates into less cost, and yet produces insights into the molecular regulation of dopamine in virtually any paradigm of the investigators' choice.
We focus the analyses in the midbrain. Although the SN and VTA are typically neglected in most studies of dopamine regulation, these nuclei are easily dissected with practice. A comprehensive readout of dopamine tissue content and TH, DAT, or VMAT2 can be conducted. There is burgeoning literature on the impact of dopamine function in the SN and VTA on behavior, and the impingements of exogenous substances or disease processes therein 1-5. Furthermore, compounds such as growth factors have a profound effect on dopamine and dopamine-regulating proteins, to a comparatively greater extent in the SN or VTA 6-8. Therefore, this methodology is presented for reference to laboratories that want to extend their inquiries on how specific treatments modulate behaviour and dopamine regulation. Here, a multi-step method is presented for the analyses of dopamine tissue content, the protein levels of TH, DAT, or VMAT2, and TH phosphorylation from the substantia nigra and VTA from rodent midbrain. The analysis of TH phosphorylation can yield significant insights into not only how TH activity is regulated, but also the signaling cascades affected in the somatodendritic nuclei in a given paradigm.
We will illustrate the dissection technique to segregate these two nuclei and the sample processing of dissected tissue that produces a profile revealing molecular mechanisms of dopamine regulation in vivo, specific for each nuclei (Figure 1).

Watch this Scientific Journal Video about Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area at JoVE.com

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Dopamine is distinctly regulated in the midbrain nuclei, which contain the cell bodies and dendrites of the dopamine neurons. Here we describe a dissection and sample-handling approach to maximize results, and thus conclusions and insights, on dopamine regulation in the midbrain nuclei of the substantia nigra (SN) and ventral tegmental area (VTA) in rodents.

Dopamine is a vigorously studied neurotransmitter in the CNS. Indeed, its involvement in locomotor activity and reward-related behaviour has fostered five ...

comprehensive-profiling-dopamine-regulation-substantia-nigra-ventral

Research

JoVE Journal

Neuroscience

25.6K Views.  Louisiana State University Health Sciences Center. Dopamine is distinctly regulated in the midbrain nuclei, which contain the cell bodies and dendrites of the dopamine neurons. Here we describe a dissection and sample-handling approach to maximize results, and thus conclusions and insights, on dopamine regulation in the midbrain nuclei of the substantia nigra (SN) and ventral tegmental area (VTA) in rodents.